Basera, Mario .

HRN: 25-41-69  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/04/2024
CEFUROXIME 750MG (VIAL)
07/04/2024
07/10/2024
IVTT
750mg
Q8h
UTI
Waiting Final Action 
07/10/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
07/10/2024
07/16/2024
IVTT
200mg
Q12
PCAP
Waiting Final Action 
07/11/2024
CEFUROXIME 500MG (TAB)
07/11/2024
07/14/2024
PO
1 Tab
BID
PCAP
Waiting Final Action 
07/11/2024
MUPIROCIN 2%, 15G (TUBE)
07/11/2024
07/18/2024
TOPICAL
As Needed
TID
Skin Ulcer
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: